| |
|
|
|
Acura Pharmaceuticals Inc.  
|
|
0.3 -0.06 (-0.17%) |
03-01 15:59 |
|
Open: |
0.41 |
Pre close: |
0.36 |
Target:
|
0.45 
|
|
High: |
0.415 |
Low: |
0.274 |
Resistance:
|
0.38
0.50
|
|
Volume: |
32,510 |
Market Cap: |
6M |
Support:
|
0.19
0.16
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.36
|
MACD |
MACD(12,26):
|
0.03 |
|
MA(20): |
0.33  |
Signal(12,26,9): |
0.03 |
|
MA(100): |
0.26 |
Stochastic Oscillator |
%K(14,3):
|
39.52 |
|
MA(250): |
0.28 |
%D(3): |
50.88 |
|
Average Volume(K) |
3-Month: |
2126
|
52-Week |
High:
|
0.50 |
|
10-Days: |
1607 |
Low: |
0.12 |
|
RSI |
RSI(14):
|
47.60 |
Change(%): |
-6.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.025 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
21.65 |
|
EPS Est. Current Year |
-0.460 |
Return on Assets (ttm) |
8.3 |
Shares Float (M) |
7.10 |
|
EPS Est. Next Year |
0.370 |
PEG Ratio |
0.00 |
% Held by Insiders |
52.81 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-69.0 |
% Held by Institutions |
9.04 |
|
Forward EPS |
-0.140 |
Gross Profit (p.s.) |
0.053 |
Shares Short (K) |
90 |
|
Book Value (p.s.) |
-0.260 |
EBITDA (p.s.) |
0.022 |
P/E |
-12.00 |
|
Sales Per Share |
0.188 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-1.15 |
|
Profit Margin |
-19.89 |
Operating Cash Flow
(M) |
-0.12 |
P/S |
1.60 |
|
Operating Margin |
7.61 |
Levered Free Cash Flow
(M) |
-0.83 |
P/CF |
-55.51 |
|
|
|
|
|
|
